D. Hurlburt

发表

Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae Among Alaskan Children

A. Schuchat, M. Moore, Sarah Y. Park, 2008, The Pediatric infectious disease journal.

Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska.

B. Schwartz, J. Butler, D. Bruden, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae — Alaska , 2000 – 2010

K. Rudolph, D. Hurlburt, T. Hennessy, 2015 .

Impact of the Pneumococcal Conjugate Vaccine and Antibiotic Use on Nasopharyngeal Colonization by Antibiotic Nonsusceptible Streptococcus pneumoniae, Alaska, 2000[FIGURE DASH]2010

K. Rudolph, D. Hurlburt, T. Hennessy, 2015, The Pediatric infectious disease journal.

Presence of cagPAI genes and characterization of vacA s, i and m regions in Helicobacter pylori isolated from Alaskans and their association with clinical pathologies.

B. McMahon, D. Bruden, K. Rudolph, 2020, Journal of medical microbiology.

Characterization of Helicobacter pylori cagA and vacA Genotypes among Alaskans and Their Correlation with Clinical Disease

B. McMahon, D. Bruden, D. Hurlburt, 2011, Journal of Clinical Microbiology.

Invasive Pneumococcal Disease in Alaskan Children: Impact of the Seven-Valent Pneumococcal Conjugate Vaccine and the Role of Water Supply

R. Singleton, J. Wenger, D. Bruden, 2010, The Pediatric infectious disease journal.

2009 Pandemic influenza A H1N1 in Alaska: temporal and geographic characteristics of spread and increased risk of hospitalization among Alaska Native and Asian/Pacific Islander people.

J. Cheek, R. Singleton, T. K. Thomas, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

H. pylori-associated pathologic findings among Alaska native patients

B. McMahon, L. Nolen, D. Bruden, 2018, International journal of circumpolar health.

Dynamics of Helicobacter pylori-Specific Immunoglobulin G for 2 Years after Successful Eradication of Helicobacter pylori Infection in an American Indian and Alaska Native Population

B. McMahon, D. Bruden, D. Hurlburt, 2006, Clinical and Vaccine Immunology.

Alaska Sentinel Surveillance Study of Helicobacter pylori Isolates from Alaska Native Persons from 2000 to 2008

B. McMahon, D. Bruden, A. Reasonover, 2011, Journal of Clinical Microbiology.

Alaska Sentinel Surveillance for Antimicrobial Resistance in Helicobacter pylori Isolates from Alaska Native Persons, 1999–2003

B. McMahon, D. Berg, M. Swenson, 2006, Helicobacter.

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection.

B. McMahon, A. Reasonover, D. Hurlburt, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.

M. Harker-Jones, K. Rudolph, D. Hurlburt, 2016, Diagnostic microbiology and infectious disease.

Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.

R. Singleton, K. Rudolph, D. Hurlburt, 2015, Vaccine.

Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986–2010

A. Reasonover, M. Harker-Jones, K. Rudolph, 2013, International journal of circumpolar health.

Haemophilus influenzae Serotype a Invasive Disease, Alaska, USA, 1983–2011

R. Singleton, J. Wenger, K. Rudolph, 2013, Emerging infectious diseases.

PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children.

J. Wenger, D. Bruden, K. Rudolph, 2014, Vaccine.

Risk Factors for Pneumococcal Colonization of the Nasopharynx in Alaska Native Adults and Children.

D. Bruden, K. Rudolph, D. Hurlburt, 2014, Journal of the Pediatric Infectious Diseases Society.

Human Seroprevalence to 11 Zoonotic Pathogens in the U.S. Arctic, Alaska.

M. Drebot, J. Petersen, J. Priest, 2019, Vector borne and zoonotic diseases.

Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults.

K. O'Brien, R. Singleton, J. Butler, 2007, Vaccine.

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity.

A. Schuchat, R. Singleton, J. Butler, 2005, Vaccine.

A prospective cohort study of immunogenicity of quadrivalent human papillomavirus vaccination among Alaska Native Children, Alaska, United States.

E. Meites, L. Markowitz, K. Rudolph, 2020, Vaccine.

Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.

R. Singleton, J. Wenger, K. Rudolph, 2014, The Journal of infectious diseases.

Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged ≥5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.

K. Rudolph, D. Hurlburt, T. Hennessy, 2018, Vaccine.

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

B. McMahon, K. Rudolph, D. Hurlburt, 2016, The Journal of infectious diseases.

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

L. Hammitt, R. Singleton, J. Butler, 2007, JAMA.

Epidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009.

J. Wenger, D. Bruden, A. Reasonover, 2013, Diagnostic microbiology and infectious disease.

Diagnostic Microbiology and Infectious Disease

J. Wenger, D. Bruden, A. Reasonover, 2013 .

The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections

B. McMahon, J. Butler, D. Bruden, 2003, Annals of Internal Medicine.

Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013

D. Bruden, A. Reasonover, K. Rudolph, 2015, Journal of Clinical Microbiology.

Molecular Resistance Mechanisms of Macrolide-Resistant Invasive Streptococcus pneumoniae Isolates from Alaska, 1986 to 2010

A. Reasonover, M. Harker-Jones, K. Rudolph, 2013, Antimicrobial Agents and Chemotherapy.

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.

L. Hammitt, J. Butler, H. Baggett, 2006, The Journal of infectious diseases.

Migration of persons between households in rural Alaska: considerations for study design

J. Wenger, D. Bruden, D. Hurlburt, 2013, International journal of circumpolar health.

Effect of high-dose amoxicillin on the prevalence of penicillin-resistant Streptococcus pneumoniae in rural Alaska.

B. Schwartz, J. Butler, D. Bruden, 2002, JAMA.

The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated for Helicobacter pylori infection

B. McMahon, D. Bruden, A. Reasonover, 2019, GastroHep.

Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population.

Michael G Bruce, B. McMahon, Julie Morris, 2011, World journal of gastroenterology.

Diagnostic Microbiology and Infectious Disease

D. Bruden, A. Reasonover, M. Harker-Jones, 2013 .